New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well

Updated on: November 07,2024

New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well

Updated on:November 07,2024

Team develops method for imaging deep brain activity with microprisms

bySPIEUsing a microprism approach for brain imaging, researchers can track and map neural activity over days. Credit:Neurophotonics(2024). DOI: 10.1117/1.NPh.11.3.033407Organisms con

Updated on: March 28,2024

Team develops method for imaging deep brain activity with microprisms

bySPIEUsing a microprism approach for brain imaging, researchers can track and map neural activity over days. Credit:Neurophotonics(2024). DOI: 10.1117/1.NPh.11.3.033407Organisms con

Updated on:March 28,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on: March 28,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on:March 28,2024

Progranulin and dementia—a blood sample does not tell the full story!

by Bentham Science PublishersProgranulin is a central protein in both neuronal survival and neurodegenerative diseases. It is thus not surprising that altered progranulin levels represent a universal

Updated on: March 07,2024

Progranulin and dementia—a blood sample does not tell the full story!

by Bentham Science PublishersProgranulin is a central protein in both neuronal survival and neurodegenerative diseases. It is thus not surprising that altered progranulin levels represent a universal

Updated on:March 07,2024

Viral infections could promote neurodegeneration

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainSome viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the journal&nbs

Updated on: April 29,2024

Viral infections could promote neurodegeneration

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainSome viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the journal&nbs

Updated on:April 29,2024

An Alzheimer's treatment would tax the US health care system

by RAND CorporationThe flow of how an Alzheimer's treatment would get to patients after approval. Credit: RAND Corp.The U.S. health care system lacks the capacity to rapidly move a treatment

Updated on: April 08,2024

An Alzheimer's treatment would tax the US health care system

by RAND CorporationThe flow of how an Alzheimer's treatment would get to patients after approval. Credit: RAND Corp.The U.S. health care system lacks the capacity to rapidly move a treatment

Updated on:April 08,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on: April 10,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on:April 10,2024

Learning a second language helps maintain a socially healthy brain in old age, finds study

bySingapore University of Technology and DesignHigher gray matter volume, larger suface area, and greater cortical thickness were associated with earlier bilingual acquisition and better perform

Updated on: March 28,2024

Learning a second language helps maintain a socially healthy brain in old age, finds study

bySingapore University of Technology and DesignHigher gray matter volume, larger suface area, and greater cortical thickness were associated with earlier bilingual acquisition and better perform

Updated on:March 28,2024

Secondary infections inflame the brain, worsening cognition in Alzheimer's disease

by Trinity College DublinCredit: Unsplash/CC0 Public DomainNew research into Alzheimer's disease (AD) suggests that secondary infections and new inflammatory events amplify the brain's im

Updated on: June 20,2024

Secondary infections inflame the brain, worsening cognition in Alzheimer's disease

by Trinity College DublinCredit: Unsplash/CC0 Public DomainNew research into Alzheimer's disease (AD) suggests that secondary infections and new inflammatory events amplify the brain's im

Updated on:June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on: June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on:June 20,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on: March 13,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on:March 13,2024

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra

Updated on: March 19,2024

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra

Updated on:March 19,2024